The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment. The trial began in July and is one of several studies launched to find some protection and another way of at least slowing the outbreak.
The drug is targeted at Bundibugyo virus, which is responsible for the fast-moving outbreak and is without an approved vaccine or treatment. The trial began in July and is one of several studies launched to find some protection and another way of at least slowing the outbreak.
<iframe src="https://statesidedaily.com/embed/cluster/69dea63b9f138d444d25c12feb678d936a2b7758" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Inside the study for a remedy to fight Congo's deadliest Ebola outbreak"></iframe>
